Experiences with
Neutropenia439 public posts
Want to take advantage of all our features? Just log in!
or
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
Neutropenia, the most common adverse event of clinical interest of grade 3 or higher, was reported in 32.3%, 46.1%, and 43.2% in the three groups.
Its a short read here: https://www.nejm.org/doi/full/10.1056/NEJMoa2409804?query=TOC&logout=true
Jackie